Methotrexate for recalcitrant cutaneous Crohn's disease: a dermatology-based case series with emphasis on outcomes

Int J Dermatol. 2023 Apr;62(4):e274-e276. doi: 10.1111/ijd.16417. Epub 2022 Aug 30.

Authors

Matthew L Hrin¹, Josiah Williams¹, Nathan L Bowers¹, Christine S Ahn¹, Lindsay C Strowd¹

Affiliation

¹ Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

PMID: 36040019
DOI: 10.1111/ijd.16417

No abstract available

Publication types

Letter

MeSH terms

Crohn Disease* / complications
Crohn Disease* / drug therapy
Dermatology*
Humans
Immunosuppressive Agents
Infliximab
Methotrexate / therapeutic use
Skin Diseases*

Substances

Methotrexate
Immunosuppressive Agents
Infliximab